
- /
- Supported exchanges
- / F
- / BUW.F
BIO-RAD LABS INC. B DL 1 (BUW F) stock market data APIs
BIO-RAD LABS INC. B DL 1 Financial Data Overview
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get BIO-RAD LABS INC. B DL 1 data using free add-ons & libraries
Get BIO-RAD LABS INC. B DL 1 Fundamental Data
BIO-RAD LABS INC. B DL 1 Fundamental data includes:
- Net Revenue: 2 554 M
- EBITDA: 410 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-28
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIO-RAD LABS INC. B DL 1 News

Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
HERCULES, Calif., October 16, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its finan...


Aurora Cannabis (ACB) Soars 6.2%: Is Further Upside Left in the Stock?
Aurora Cannabis Inc. (ACB) shares rallied 6.2% in the last trading session to close at $6.17. This move can be attributable to notable volume with a higher number of shares being traded than in a typi...

Multi-Plex Immunoassays Market to Reach US$ 6.90 Billion by 2033 as Precision Medicine and Biomarker Discovery Fuel Global Adoption | DataM Intelligence
AUSTIN, Texas and TOKYO, Oct. 7, 2025 /PRNewswire/ -- The Multi-Plex Immunoassays Market is entering a new era of growth as clinical diagnostics, drug discovery, and personalized medicine increasingl...

Bio-Rad Laboratories (BIO): Is the Current Valuation Justified After Recent Share Price Uptick?
Bio-Rad Laboratories (BIO) has seen its stock edge upward over the past week, catching some attention among investors. Shares closed at $297.95, reflecting modest gains that contrast with longer-term ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.